Schedule 13G ownership disclosure
ALDER BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 014339105
Event date: 2016-10-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 951,885
- Percent of class
- 1.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-131747
- Form type
- SC 13G
- Filer
- ALDER BIOPHARMACEUTICALS INC
- CIK
- CIK 1423824
- Filed
- Nov 04, 2016
- Reporting period
- Oct 27, 2016
- Description
- Schedule 13G beneficial ownership